Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Over the past month, shares of this biotechnology company have returned +11.6%, compared to the Zacks S&P 500 composite's +1.3% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Moderna falls in, has gained 0.8%. The key question now is: What could be the stock's future direction ...